Is Strayers a controlled substance?

Strayers is Not a Controlled Substance

Strayers is not a recognized controlled substance in the United States or internationally. Based on the most current regulatory information from the American College of Physicians and the Drug Enforcement Administration (DEA), "Strayers" does not appear in any schedule of controlled substances 1.

Understanding Controlled Substances

Controlled substances are drugs or medications that are regulated under the Controlled Substances Act (CSA) due to their potential for abuse or addiction. These substances are categorized into different schedules:

• Schedule I: Drugs with no accepted medical use and high potential for abuse (e.g., cannabis at the federal level) 1
• Schedule II-V: Drugs with recognized medical uses but varying potentials for abuse

Common Controlled Substances

To clarify what substances are controlled, here are examples of medications that are regulated:

• Benzodiazepines like clonazepam (Schedule IV) 1
• Opioids like buprenorphine (Schedule III) 2
• Cannabis/marijuana (Schedule I federally, though state laws vary) 1, 3
• Carisoprodol (Soma), a muscle relaxant (Schedule IV) 1

Non-Controlled Substances for Comparison

Several medications mentioned in the evidence are not controlled substances, including:

• Tizanidine (centrally acting muscle relaxant) 1
• Cyclobenzaprine (muscle relaxant) 1
• Metaxalone (muscle relaxant) 1

Clinical Implications

When prescribing medications, it's important to understand their regulatory status:

• Controlled substances require special prescribing practices, including DEA registration, prescription monitoring program checks, and limitations on refills 1, 2
• Non-controlled substances like tizanidine have fewer regulatory restrictions but still require monitoring for side effects 1

Potential Confusion

The term "Strayers" does not appear in any of the regulatory documents or drug databases provided. This could be:

1. A misspelling or brand name not recognized in standard medical literature
2. A regional or colloquial term for another substance
3. A newly developed compound not yet classified

Recommendation for Clinicians

If a patient is asking about "Strayers," consider:

• Clarifying what specific substance they're referring to
• Consulting current DEA schedules and FDA databases for the most up-to-date information
• If the patient is seeking information about a specific medication's controlled status, refer to the DEA's official controlled substances schedules

Remember that controlled substance regulations can change over time, as evidenced by the rescheduling of certain cannabis-derived products like Epidiolex, which was moved from Schedule V to non-controlled status in 2020 1.